Evidence map›Paper›PMID 25787281›Full record

ArticleJournal of virology2015

Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice.

Ram P Kamal, Amrita Kumar, Charles T Davis, Wen-Pin Tzeng, Tung Nguyen, Ruben O Donis, Jacqueline M Katz, Ian A York

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Accessory Gene Products of Influenza A Virus.Cold Spring Harbor perspectives in medicine · 2021
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. A review of H5Nx avian influenza viruses.Therapeutic advances in vaccines and immunotherapy · 2019
    Review
  16. Article
  17. Article
  18. Evolution and Virulence of Influenza A Virus Protein PB1-F2.International journal of molecular sciences · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ram P KamalInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Battelle Memorial Institute, Atlanta, Georgia, USA.
Amrita KumarInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Battelle Memorial Institute, Atlanta, Georgia, USA.
Charles T DavisInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Wen-Pin TzengInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Tung NguyenNational Centre for Veterinary Diagnostics, Department of Animal Health, Hanoi, Vietnam.
Ruben O DonisInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jacqueline M KatzInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ian A YorkInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA ITE1@cdc.gov.
Centers for Disease Control and Prevention · USNational Institute of Veterinary Research · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledInfluenza A viruses (IAVs) express the PB1-F2 protein from an alternate reading frame within the PB1 gene segment. The roles of PB1-F2 are not well understood but appear to involve modulation of host cell responses. As shown in previous studies, we find that PB1-F2 proteins of mammalian IAVs frequently have premature stop codons that are expected to cause truncations of the protein, whereas avian IAVs usually express a full-length 90-amino-acid PB1-F2. However, in contrast to other avian IAVs, recent isolates of highly pathogenic H5N1 influenza viruses had a high proportion of PB1-F2 truncations (15% since 2010; 61% of isolates in 2013) due to several independent mutations that have persisted and expanded in circulating viruses. One natural H5N1 IAV containing a mutated PB1-F2 start codon (i.e., lacking ATG) was 1,000-fold more virulent for BALB/c mice than a closely related H5N1 containing intact PB1-F2. In vitro, we detected expression of an in-frame protein (C-terminal PB1-F2) from downstream ATGs in PB1-F2 plasmids lacking the well-conserved ATG start codon. Transient expression of full-length PB1-F2, truncated (24-amino-acid) PB1-F2, and PB1-F2 lacking the initiating ATG in mammalian and avian cells had no effect on cell apoptosis or interferon expression in human lung epithelial cells. Full-length and C-terminal PB1-F2 mutants colocalized with mitochondria in A549 cells. Close monitoring of alterations of PB1-F2 and their frequency in contemporary avian H5N1 viruses should continue, as such changes may be markers for mammalian virulence. IMPORTANCE: Although most avian influenza viruses are harmless for humans, some (such as highly pathogenic H5N1 avian influenza viruses) are capable of infecting humans and causing severe disease with a high mortality rate. A number of risk factors potentially associated with adaptation to mammalian infection have been noted. Here we demonstrate that the protein PB1-F2 is frequently truncated in recent isolates of highly pathogenic H5N1 viruses. Truncation of PB1-F2 has been proposed to act as an adaptation to mammalian infection. We show that some forms of truncation of PB1-F2 may be associated with increased virulence in mammals. Our data support the assessment of PB1-F2 truncations for genomic surveillance of influenza viruses.

Indexed as

AnimalsApoptosisCell LineCodon, NonsenseDisease Models, AnimalEpithelial CellsFemaleHumansInfluenza A Virus, H5N1 SubtypeInterferonsMice, Inbred BALB COrthomyxoviridae InfectionsViral ProteinsVirulenceVirulence FactorsCodon, NonsenseInterferonsPB1-F2 protein, Influenza A virusViral ProteinsVirulence Factors

Identifiers

PMID25787281
PMCPMC4442455
OpenAlexW2109702167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.